TELA
NASDAQ
$0.72
TELA Bio Inc (TELA)
TELA Bio, Inc., a medical technology company, focuses on the design, development and commercialization of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is headquartered in Malvern, Pennsylvania.
Sector:
Healthcare
Industry:
Medical Devices
Target: $2.25 (+212.46%)
Market Cap
$35M
Revenue 5Y CAGR
+31.74%
Free Cash Flow Yield
-85.90%
Beta (5Y)
0.81
Price Chart
Valuation
Market Cap$35M
P/S0.43
P/B7.30
Profitability
Total Revenue (TTM)$81M
Gross Profit (TTM)$55M
EBITDA-$33M
Profit Margin-64.4%
Operating Margin-55.2%
EPS-$0.94
Financial Health
Debt-to-Equity-1074.1%
Free Cash Flow Yield-85.90%
Growth & Risk
EPS 5Y CAGR-14.49%
Revenue 5Y CAGR+31.74%
FCF 5Y CAGR+3.15%
Beta (5Y)0.81
Sharpe Ratio-0.77